[ET Net News Agency, 21 July 2021] WuXi Biologics (Cayman) Inc. (02269) said it was
informed by WuXi Biologics Holdings Limited (Biologics Holdings), one of the substantial
shareholders of the company, that it has entered into a block trade agreement with Morgan
Stanley & Co. International PLC (the placing agent). The placing agent has agreed to place
80 million existing shares of the company (representing approximately 1.89% of the total
issued share capital of the company) held by Biologics Holdings to parties independent of
and not connected with the company at a price of HK$129 each.
Assuming the placing will be completed as contemplated, the shareholding held by
Biologics Holdings in the company will decrease from approximately 17.22% to 15.34% of the
total issued share capital of the company. (RC)